MGNX MacroGenics, Inc. - Common Stock
NASDAQ · Biotechnology · SEC EDGAR'da Görüntüle ↗ kapat Eki 2, 2026 10-K/10-Q Ağu 14, 2026
$3,58
· 52 haftalık aralığın %'i
· düşüğün üstünde
· yükseğe
$1,2952 haftanın en düşüğü
$5,0852 haftanın en yükseği
Piyasa Değeri (MRQ)
$228M
P/E (TTM)
-15.6
Hisse Başına Kâr (TTM)
$-0.23
Gelir (TTM)
$168M
rozetleriniz
52 Haftlık Aralık
$1–$5
Analist Derecelendirmesi
BUY
Fiyat Hedefi
$8
P/E
-15.6
ROE
-32.6%
Net Kâr Marjı
-8.7%
Rozet şeridiniz boş — bu sayfada herhangi bir metriği sabitleyin.
MGNX Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$3.58
Piyasa Değeri (MRQ)
$228M
P/E (TTM)
-15.6
Hisse Başına Kâr (TTM)
$-0.23
Gelir (TTM)
$168M
ROE (TTM)
-32.6%
52 Haftlık Aralık
$1–$5
MGNX Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
aralık
çubuklar
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir$150M2016-12-31 → 2025-12-31
Hisse Başına Kâr$-1.182020-12-31 → 2025-12-31
Serbest Nakit Akışı$-83M2016-12-31 → 2025-12-31
Net kar marjı-8.7%2016-12-31 → 2025-12-31
Değerleme ve Oranlar
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | MGNX | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| P/E (TTM) | -15.65Y ort. ≈-15.3 | ≈-15.3 | · | · | |
| F/S (TTM) | 1.45Y ort. ≈5.5 | ≈5.5 | 29.5 | Düşük değerli | |
| F/D (MRQ) | 5.35Y ort. ≈2.9 | ≈2.9 | 4.9 | Daha pahalı | |
| Fiyat / Serbest Nakit Akışı (TTM) | -3.55Y ort. ≈-4.5 | ≈-4.5 | · | · | |
| Fiyat / Nakit Akışı (TTM) | -3.65Y ort. ≈-4.7 | ≈-4.7 | · | · | |
| Price / Tangible Book (Fiyat / Maddi Defter Değeri) | 4.15Y ort. ≈2.9 | ≈2.9 | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | MGNX | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Faaliyet Kâr Marjı (TTM) | -24.3%5Y ort. ≈-150.1% | ≈-150.1% | -680.6% | En üst düzey | |
| FAVÖK Marjı (TTM) | -20.8%5Y ort. ≈-140.4% | ≈-140.4% | -664.4% | En üst düzey | |
| Pretax Margin (Vergi Öncesi Kar Marjı) | -50.4% | · | · | · | |
| Net Kâr Marjı (TTM) | -8.7%5Y ort. ≈-90.0% | ≈-90.0% | -1229.7% | En üst düzey | |
| ROA (TTM) | -4.9%5Y ort. ≈-30.3% | ≈-30.3% | -29.4% | Aynı seviyede | |
| ROE (TTM) | -32.6%5Y ort. ≈-56.2% | ≈-56.2% | -41.9% | Zayıf | |
| ROIC | -129.9% | · | · | · |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | MGNX | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Cari Oran (MRQ) | 3.05Y ort. ≈4.4 | ≈4.4 | 5.4 | Düşük likidite | |
| Quick Ratio (Cari Oran) | 1.65Y ort. ≈2.4 | ≈2.4 | 4.6 | Düşük likidite |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
| Metrik | 5 Yıllık trend | MGNX | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Revenue YoY (Gelir Yıllık Bazda) | -0.31%5Y ort. ≈32.7% | ≈32.7% | · | · | |
| Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı) | -0.54%5Y ort. ≈2.2% | ≈2.2% | · | · | |
| Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı) | 7.3% | · | · | · |
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
| Metrik | 5 Yıllık trend | MGNX | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Asset Turnover (Aktif Devir Hızı) | 0.65Y ort. ≈0.4 | ≈0.4 | 0.1 | En üst düzey | |
| Inventory Turnover (Stok Devir Hızı) | 0.05Y ort. ≈0.8 | ≈0.8 | · | · | |
| Receivables Turnover (Alacak Devir Hızı) | 16.95Y ort. ≈9.7 | ≈9.7 | · | · | |
| Revenue / Employee (Çalışan Başına Gelir) | ≈$510.2K | · | · | · |
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
16.8%
Sonraki Rapor
Kas 10, 2026
| Dönem | Rapor | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|---|
| 30 Haziran 2026 | Ağu 13, 2026 | $-0.26 | $-0.13 | -102.7% |
| 31 Mart 2026 | May 13, 2026 | $-0.58 | $-0.58 | 0.45% |
| 31 Aralık 2025 | $-0.23 | $-0.30 | 22.4% | |
| 30 Eylül 2025 | $0.27 | $-0.50 | 153.8% | |
| 30 Haziran 2025 | $-0.57 | $-0.62 | 8.1% | |
| 31 Mart 2025 | $-0.65 | $-0.80 | 18.5% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $150M | $150M | $59M | $152M | $77M | $105M | $64M | $60M | $158M | $92M | $101M | $48M | |
| Cost of Revenue | $0 | $847.0K | $619.0K | $3M | $3M | $0 | $0 | · | · | · | · | · | |
| R&D Expense | $147M | $177M | $167M | $207M | $215M | $193M | $195M | $191M | $147M | $122M | $98M | $70M | |
| SG&A Expense | $39M | $71M | $52M | $59M | $63M | $43M | $46M | $40M | $33M | $30M | $23M | $16M | |
| Operating Expenses | $222M | $261M | $227M | $273M | $280M | $236M | $241M | $231M | $180M | $152M | $121M | $86M | |
| Operating Income | $-73M | $-111M | $-168M | $-121M | $-203M | $-131M | $-177M | $-171M | $-22M | $-60M | $-20M | $-38M | |
| Interest Expense | · | $1M | $1M | $0 | $0 | · | · | · | · | · | · | · | |
| Other Non-op | $6M | $9M | $10M | $2M | $680.0K | $1M | $25M | $-247.0K | $3M | $2M | $42.0K | $2.0K | |
| Pretax Income | $-75M | $-66M | $-9M | $-120M | · | · | · | · | · | · | · | · | |
| Income Tax | $-672.0K | $944.0K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-75M | $-67M | $-9M | $-120M | $-202M | $-130M | $-152M | $-171M | $-20M | $-59M | $-20M | $-38M | |
| EPS (Basic) | $-1.18 | $-1.07 | $-0.15 | $-1.95 | $-3.37 | $-2.47 | · | · | · | · | · | $-1.40 | |
| EPS (Diluted) | $-1.18 | $-1.07 | $-0.15 | $-1.95 | $-3.37 | $-2.47 | · | · | · | · | · | $-1.40 | |
| Shares (Basic) | 63,155,096 | 62,621,185 | 61,929,198 | 61,433,124 | 59,944,717 | 52,442,389 | 48,082,728 | · | 36,095,080 | 34,685,274 | 31,801,645 | 27,384,990 | |
| Shares (Diluted) | 63,155,096 | 62,621,185 | 61,929,198 | 61,433,124 | 59,944,717 | 52,442,389 | 48,082,728 | · | 36,095,080 | 34,685,274 | 31,801,645 | 27,384,990 | |
| EBITDA | $-66M | $-103M | $-159M | $-110M | $-192M | $-119M | · | $-163M | $-15M | $-52M | $-17M | · |
Bilanço
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $57M | $183M | $101M | $109M | $123M | $181M | $126M | $220M | $212M | $84M | $196M | $158M | |
| Short-term Investments | · | · | · | · | · | · | $89M | $13M | $93M | $193M | $143M | · | |
| Receivables | $427.0K | $4M | $10M | $56M | $10M | $23M | $13M | $30M | $14M | $3M | $1M | $3M | |
| Inventory | $8M | $0 | $1M | $1M | $4M | $0 | · | · | · | · | · | · | |
| Prepaid Expense | $7M | $12M | $10M | $10M | $21M | $17M | $11M | $7M | $3M | $3M | $2M | $4M | |
| Current Assets | $220M | $217M | $251M | $222M | $280M | $313M | $240M | $269M | $322M | $284M | $342M | $165M | |
| PP&E (Net) | $2M | $18M | $22M | $30M | $38M | $42M | $48M | $57M | $50M | $18M | $15M | $7M | |
| PP&E (Gross) | $108M | $107M | $110M | $114M | $110M | $104M | $98M | $95M | $79M | $44M | $35M | $24M | |
| Accum. Depreciation | $96M | $89M | $88M | $84M | $73M | $62M | $50M | $38M | $29M | $26M | $20M | $17M | |
| Other Non-current Assets | $207.0K | $2M | $1M | $1M | $1M | $24M | $25M | $6M | $2M | $1M | $2M | $2M | |
| Total Assets | $257M | $262M | $298M | $280M | $335M | $379M | $313M | $332M | $374M | $311M | $359M | $174M | |
| Accounts Payable | $3M | $5M | $6M | $5M | $16M | $8M | $4M | $4M | $2M | $4M | $3M | $2M | |
| Accrued Liabilities | $22M | $29M | $24M | $29M | $34M | $34M | $27M | $33M | $39M | $16M | $12M | $8M | |
| Current Liabilities | $43M | $56M | $56M | $49M | $75M | $51M | $45M | $60M | $50M | $27M | $24M | $27M | |
| Capital Leases | $31M | $33M | $30M | $30M | $21M | $25M | $28M | $0 | · | · | · | · | |
| Other Non-current Liabilities | $1M | $2M | $258.0K | $258.0K | $258.0K | $0 | $0 | · | · | · | $0 | · | |
| Total Liabilities | $201M | $146M | $146M | $138M | $96M | $83M | $82M | $89M | $75M | $43M | $46M | $53M | |
| Common Stock | $633.0K | $628.0K | $621.0K | $617.0K | $613.0K | $562.0K | $490.0K | $424.0K | $369.0K | $349.0K | $343.0K | $280.0K | |
| Paid-in Capital | · | · | · | · | · | · | · | · | · | · | · | $335M | |
| Retained Earnings | $-1.24B | $-1.17B | $-1.10B | $-1.09B | $-974M | $-772M | $-642M | $-490M | $-312M | $-293M | $-234M | $-214M | |
| Treasury Stock | · | · | · | · | · | · | · | · | · | · | $0 | $19.0K | |
| Stockholders' Equity | $56M | $116M | $153M | $142M | $240M | $296M | $231M | $243M | $299M | $269M | $313M | $121M | |
| Liabilities + Equity | $257M | $262M | $298M | $280M | $335M | $379M | $313M | $332M | $374M | $311M | $359M | $174M | |
| Shares Outstanding | 63,318,613 | 62,819,857 | 62,070,627 | 61,701,467 | 61,307,428 | 56,244,771 | 48,958,763 | 42,353,301 | 36,859,077 | 34,870,607 | 34,345,754 | 27,995,638 |
Nakit Akışı
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $7M | $8M | $10M | $12M | $11M | $12M | $12M | $9M | $7M | $8M | $3M | $2M | |
| Stock-based Comp | $14M | $29M | $18M | $20M | $23M | $21M | $20M | $17M | $15M | $12M | $8M | $3M | |
| Other Non-cash | $-28M | $-38M | $-97M | $496.0K | $24M | $-15M | · | $-7M | $12M | $-5M | $-5M | · | |
| Operating Cash Flow | $-81M | $-68M | $-78M | $-87M | $-144M | $-112M | $-134M | $-153M | $14M | $-44M | $-14M | $-33M | |
| CapEx | $2M | $4M | $2M | $4M | $6M | $6M | $4M | $25M | $29M | $11M | $9M | $4M | |
| Investing Cash Flow | $-114M | $149M | $-80M | $71M | $-37M | $-8M | $-79M | $57M | $78M | · | · | · | |
| Stock Issued | $0 | $0 | $616.0K | $1M | $118M | $170M | $119M | $103M | $34M | $0 | $203M | $77M | |
| Net Stock Activity | $0 | $0 | $616.0K | $1M | $118M | $170M | · | $103M | $34M | $0 | $203M | · | |
| Financing Cash Flow | $70M | $960.0K | $150M | $2M | $123M | $174M | $120M | $105M | $35M | · | · | · | |
| Net Change in Cash | $-126M | $82M | $-8M | $-15M | $-58M | $55M | $-94M | $8M | $128M | $-112M | $39M | $41M | |
| Free Cash Flow | $-83M | $-72M | $-80M | $-91M | $-150M | $-118M | · | $-178M | $-15M | $-55M | $-23M | · | |
| Levered FCF | · | $-73M | · | · | · | · | · | · | · | · | · | · |
Kârlılık
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -48.7% | -73.7% | -286.4% | -79.9% | -261.9% | -125.0% | · | -284.8% | -14.0% | -65.3% | -20.0% | · | |
| Net Margin | -49.9% | -44.7% | -15.4% | -78.8% | -261.0% | -123.7% | · | -285.2% | -12.4% | -63.7% | -20.0% | · | |
| Pretax Margin | -50.4% | -44.0% | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -43.9% | -68.7% | -270.0% | -72.1% | -247.3% | -113.6% | · | -271.0% | -9.5% | -57.1% | -16.8% | · | |
| ROA | -28.8% | -23.9% | -3.1% | -38.9% | -56.6% | -37.5% | · | -48.6% | -5.7% | -17.5% | -7.6% | · | |
| ROE | -87.0% | -49.9% | -6.2% | -62.8% | -75.5% | -49.3% | · | -63.2% | -6.9% | -20.1% | -9.3% | · | |
| ROIC | -129.9% | -96.6% | · | · | · | · | · | · | · | · | · | · |
Likidite ve Solventlik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.1 | 3.9 | 4.5 | 4.6 | 3.7 | 6.2 | · | 4.5 | 6.5 | 10.4 | 14.7 | · | |
| Quick Ratio | 1.6 | 3.4 | 2.0 | 3.4 | 1.8 | 4.0 | · | 4.4 | 6.4 | 10.2 | 8.5 | · | |
| Interest Coverage | · | -99.2 | -117.7 | · | · | · | · | · | · | · | · | · |
Verimlilik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.6 | 0.5 | 0.2 | 0.5 | 0.2 | 0.3 | · | 0.2 | 0.5 | 0.3 | 0.4 | · | |
| Inventory Turnover | 0.0 | 1.4 | 0.5 | 1.1 | 1.2 | · | · | · | · | · | · | · | |
| Receivables Turnover | 16.9 | 20.4 | 1.8 | 4.6 | 4.6 | 5.9 | · | 2.8 | 19.2 | 46.1 | 48.5 | · |
Hisse Başına
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.88 | $1.85 | $2.46 | $2.30 | $3.91 | $5.26 | · | $5.73 | $8.12 | $7.71 | $9.12 | · | |
| Revenue / Share | $2.37 | $2.39 | $0.95 | $2.47 | $1.29 | · | · | · | $4.37 | $2.65 | $3.17 | · | |
| Cash Flow / Share | $-1.28 | $-1.09 | $-1.26 | $-1.42 | $-2.40 | · | · | · | $0.40 | $-1.26 | $-0.43 | · | |
| Cash / Share | $0.90 | $2.91 | $1.63 | $1.76 | $2.01 | $3.22 | · | $5.20 | $5.74 | $2.41 | $5.71 | · | |
| EPS (TTM) | $-1.18 | $-1.07 | $-0.15 | $-1.95 | $-3.37 | $-2.47 | $-0.70 | $-0.70 | $-0.70 | $-1.73 | $-0.58 | $-1.40 |
Büyüme Oranları
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -0.31% | 155.3% | -61.3% | 96.2% | -26.2% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -0.54% | 24.6% | -17.6% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 7.3% | · | · | · | · | · | · | · | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $150M | $150M | $59M | $152M | $77M | $105M | $64M | $60M | $158M | $92M | $101M | $48M | |
| Net Income TTM | $-75M | $-67M | $-9M | $-120M | $-202M | $-130M | $-152M | $-171M | $-20M | $-59M | $-20M | $-38M | |
| Market Cap | $102M | $204M | $597M | $414M | $984M | $1.29B | · | $538M | $700M | $713M | $1.06B | · | |
| P/E | -1.4 | -3.0 | -64.1 | -3.4 | -4.8 | -9.3 | -15.5 | -18.1 | -27.1 | -11.8 | -53.4 | -25.1 | |
| P/S | 0.7 | 1.4 | 10.2 | 2.7 | 12.7 | 12.3 | · | 8.9 | 4.4 | 7.8 | 10.5 | · | |
| P/B | 1.8 | 1.8 | 3.9 | 2.9 | 4.1 | 4.3 | · | 2.2 | 2.3 | 2.7 | 3.4 | · | |
| P / Tangible Book | 1.8 | 1.8 | 3.9 | 2.9 | 4.1 | 4.3 | · | · | · | · | · | · | |
| P / Cash Flow | -1.3 | -3.0 | -7.6 | -4.8 | -6.8 | -11.5 | · | -3.5 | 48.6 | -16.3 | -77.9 | · | |
| P / FCF | -1.2 | -2.8 | -7.5 | -4.6 | -6.6 | -10.9 | · | -3.0 | -46.7 | -12.9 | -46.5 | · | |
| Earnings Yield | -73.3% | -32.9% | -1.6% | -29.1% | -21.0% | -10.8% | -6.4% | -5.5% | -3.7% | -8.5% | -1.9% | -4.0% |
Gelir Tablosu
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $33M | $21M | $41M | $73M | $7M | $13M | $19M | $111M | $11M | $9M | $10M | $13M | $24M | $73M | $42M | $26M | |
| Cost of Revenue | · | · | $0 | $0 | $0 | $0 | $233.0K | $168.0K | $176.0K | $270.0K | $85.0K | $258.0K | $113.0K | $116.0K | $3M | $180.0K | |
| R&D Expense | $39M | $35M | $34M | $33M | $41M | $40M | $39M | $41M | $52M | $46M | $30M | $43M | $46M | $46M | $48M | $52M | |
| SG&A Expense | $8M | $10M | $9M | $10M | $9M | $11M | $28M | $14M | $14M | $15M | $12M | $14M | $14M | $14M | $15M | $14M | |
| Operating Expenses | $47M | $54M | $53M | $54M | $50M | $56M | $72M | $57M | $69M | $63M | $46M | $58M | $63M | $61M | $67M | $68M | |
| Operating Income | $-14M | $-33M | $-12M | $19M | $-43M | $-43M | $-53M | $54M | $-58M | $-54M | $-36M | $-45M | $-38M | $12M | $-25M | $-42M | |
| Interest Expense | $4M | $5M | · | $3M | $802.0K | $91.0K | · | $0 | $6.0K | $1M | $0 | $774.0K | $656.0K | $0 | $0 | $0 | |
| Other Non-op | · | · | · | · | · | · | · | · | · | · | · | · | · | $819.0K | $142.0K | $504.0K | |
| Pretax Income | $-70M | · | $-15M | $17M | $-43M | · | $-14M | $56M | $-56M | · | · | · | · | · | · | · | |
| Income Tax | $0 | · | $-777.0K | $0 | $105.0K | · | $944.0K | $0 | $0 | · | · | · | · | · | · | · | |
| Net Income | $20M | $-37M | $-14M | $17M | $-36M | $-41M | $-15M | $56M | $-56M | $-52M | $18M | $57M | $-38M | $13M | $-25M | $-41M | |
| EPS (Basic) | $0.31 | $-0.58 | $-0.23 | $0.27 | $-0.57 | $-0.65 | $-0.24 | $0.90 | $-0.89 | $-0.84 | $0.28 | $0.93 | $-0.61 | $0.20 | $-0.40 | $-0.67 | |
| EPS (Diluted) | $0.31 | $-0.58 | $-0.23 | $0.27 | $-0.57 | $-0.65 | $-0.24 | $0.90 | $-0.89 | $-0.84 | $0.28 | $0.92 | $-0.61 | $0.20 | $-0.40 | $-0.67 | |
| Shares (Basic) | 63,594,453 | 63,449,780 | · | 63,233,266 | 63,136,057 | 62,965,415 | · | 62,744,005 | 62,663,677 | 62,290,538 | 61,980,680 | 61,880,096 | 61,809,817 | · | 61,459,831 | 61,384,943 | |
| Shares (Diluted) | 63,594,453 | 63,449,780 | · | 63,283,624 | 63,136,057 | 62,965,415 | · | 62,865,841 | 62,663,677 | 62,290,538 | 62,244,602 | 62,261,646 | 61,809,817 | · | 61,459,831 | 61,384,943 | |
| EBITDA | $-14M | $-32M | · | $19M | $-37M | $-41M | · | $54M | $-58M | $-52M | $-36M | $-45M | $-35M | · | $-25M | $-42M |
Bilanço
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $114M | $67M | $57M | $80M | $131M | $146M | $183M | $180M | $84M | $80M | $90M | $109M | $224M | · | $84M | $21M | |
| Receivables | $25M | $10M | $13M | $69M | $13M | $11M | $4M | $9M | $6M | $7M | $25M | $6M | $36M | · | $14M | $18M | |
| Inventory | · | $9M | $8M | $9M | $9M | $9M | $0 | $3M | $1M | $1M | $1M | $1M | $1M | · | $1M | $3M | |
| Prepaid Expense | $4M | $8M | $9M | $8M | $7M | $8M | $12M | $10M | $9M | $10M | $9M | $6M | $10M | · | $9M | $13M | |
| Current Assets | $322M | $183M | $220M | $232M | $205M | $182M | $217M | $222M | $157M | $203M | $291M | $255M | $289M | · | $148M | $168M | |
| PP&E (Net) | $2M | $11M | $13M | $14M | $15M | $17M | $18M | $19M | $20M | $21M | $23M | $24M | $27M | · | $32M | $34M | |
| PP&E (Gross) | · | · | $108M | · | · | · | $107M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $96M | · | · | · | $89M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $195.0K | $1M | $1M | $1M | $1M | $1M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | · | $16M | $16M | |
| Total Assets | $345M | $218M | $257M | $271M | $245M | $225M | $262M | $264M | $201M | $248M | $340M | $306M | $343M | · | $195M | $218M | |
| Accounts Payable | $3M | $4M | $5M | $6M | $5M | $7M | $5M | $7M | $5M | $11M | $3M | $4M | $4M | · | $5M | $3M | |
| Accrued Liabilities | $30M | $18M | $22M | $23M | $21M | $28M | $29M | $25M | $24M | $18M | $25M | $28M | $28M | · | $33M | $32M | |
| Current Liabilities | $109M | $96M | $43M | $44M | $39M | $55M | $56M | $59M | $58M | $56M | $51M | $45M | $46M | · | $50M | $51M | |
| Capital Leases | $30M | $31M | $32M | $32M | $32M | $32M | $33M | $29M | $30M | $30M | $30M | $30M | $30M | · | $17M | $18M | |
| Other Non-current Liabilities | $450.0K | $727.0K | $1M | $1M | $2M | $2M | $2M | $258.0K | $258.0K | $258.0K | $258.0K | $258.0K | $258.0K | · | $258.0K | $258.0K | |
| Total Liabilities | $303M | $197M | $201M | $204M | $199M | $145M | $146M | $144M | $143M | $142M | $146M | $134M | $234M | · | $72M | $76M | |
| Common Stock | $637.0K | $636.0K | $633.0K | $633.0K | $632.0K | $631.0K | $628.0K | $627.0K | $627.0K | $626.0K | $620.0K | $619.0K | $618.0K | · | $615.0K | $615.0K | |
| Retained Earnings | $-1.26B | $-1.28B | $-1.24B | $-1.23B | $-1.25B | $-1.21B | $-1.17B | $-1.15B | $-1.21B | $-1.15B | $-1.06B | $-1.07B | $-1.13B | · | $-1.11B | $-1.08B | |
| Stockholders' Equity | $43M | $21M | $56M | $67M | $47M | $79M | $116M | $120M | $58M | $106M | $194M | $172M | $109M | $142M | $123M | $142M | |
| Liabilities + Equity | $345M | $218M | $257M | $271M | $245M | $225M | $262M | $264M | $201M | $248M | $340M | $306M | $343M | · | $195M | $218M | |
| Shares Outstanding | 63,645,711 | 63,560,068 | 63,318,613 | 63,258,532 | 63,205,703 | 63,090,323 | 62,819,857 | 62,763,120 | 62,720,969 | 62,560,502 | 62,028,904 | 61,938,493 | 61,838,565 | · | 61,462,189 | 61,458,790 |
Nakit Akışı
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $708.0K | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $3M | |
| Stock-based Comp | $2M | $3M | $3M | $4M | $4M | $4M | $11M | $6M | $7M | $6M | $5M | $4M | $5M | $5M | $5M | $5M | |
| Other Non-cash | · | $-3M | · | · | · | $-12M | · | · | · | $-847.0K | · | · | $17M | · | · | · | |
| Operating Cash Flow | $-41M | $-36M | $43M | $-30M | $-47M | $-47M | $-38M | $60M | $-44M | $-46M | $-35M | $-2M | $-13M | $29M | $-9M | $-49M | |
| CapEx | $806.0K | $344.0K | $244.0K | $426.0K | $715.0K | $529.0K | $620.0K | $592.0K | $1M | $1M | $499.0K | $286.0K | $359.0K | $393.0K | $804.0K | $1M | |
| Investing Cash Flow | $28M | $45M | $-66M | $-20M | $-38M | $10M | $41M | $36M | $47M | $25M | $-34M | $-113M | $28M | $-6M | $72M | $23M | |
| Stock Issued | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $616.0K | $1M | $0 | $0 | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | $0 | · | · | $616.0K | · | · | · | |
| Financing Cash Flow | $60M | $-207.0K | $57.0K | $0 | $70M | $-282.0K | $155.0K | $-68.0K | $625.0K | $248.0K | $50M | $59.0K | $100M | $1M | $0 | $263.0K | |
| Net Change in Cash | $47M | $9M | $-23M | $-51M | $-15M | $-37M | $3M | $96M | $4M | $-21M | $-19M | $-116M | $115M | $25M | $63M | $-26M | |
| Free Cash Flow | · | $-36M | · | · | · | $-47M | · | · | · | $-47M | · | · | $-13M | · | · | · |
Kârlılık
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -42.2% | -161.0% | · | 25.6% | -165.3% | -323.1% | · | 48.9% | -538.9% | -590.4% | -341.5% | -342.3% | -156.9% | · | -59.8% | -160.8% | |
| Net Margin | 59.4% | -177.0% | · | 23.1% | -163.0% | -311.1% | · | 50.9% | -515.5% | -573.3% | 168.8% | 437.5% | -155.2% | · | -59.5% | -158.8% | |
| Pretax Margin | -212.1% | · | · | 23.1% | -162.5% | · | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -42.2% | -152.8% | · | 25.6% | -165.3% | -309.7% | · | 48.9% | -538.9% | -570.2% | -341.5% | -342.3% | -144.7% | · | -59.8% | -160.8% | |
| ROA | 6.6% | -16.6% | · | 6.3% | -16.2% | -17.4% | · | 18.6% | -22.0% | -17.6% | 6.6% | 21.9% | -12.4% | · | -8.5% | -12.8% | |
| ROE | 43.6% | -73.3% | · | 18.0% | -69.4% | -44.3% | · | 35.9% | -48.5% | -48.4% | 11.1% | 36.6% | -26.4% | · | -12.0% | -17.9% | |
| ROIC | -32.3% | · | · | 27.8% | -79.1% | · | · | · | · | · | · | · | · | · | · | · |
Likidite ve Solventlik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.0 | 1.9 | · | 5.2 | 5.3 | 3.3 | · | 3.7 | 2.7 | 3.6 | 5.7 | 5.6 | 6.3 | · | 3.0 | 3.3 | |
| Quick Ratio | 1.3 | 0.8 | · | 3.4 | 3.7 | 2.8 | · | 3.2 | 1.6 | 1.6 | 2.2 | 2.6 | 5.7 | · | 2.0 | 0.8 | |
| Interest Coverage | -3.2 | -6.8 | · | 5.6 | -45.8 | -468.4 | · | · | -9696.8 | -47.4 | · | -58.1 | · | · | · | · |
Verimlilik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.3 | 0.1 | 0.1 | · | 0.4 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | · | 0.1 | 0.1 | |
| Inventory Turnover | · | · | · | 0.0 | 0.0 | 0.0 | · | 0.1 | 0.1 | 0.2 | 0.1 | 0.1 | 0.0 | · | 1.2 | 0.0 | |
| Receivables Turnover | 1.8 | 2.0 | · | 1.9 | 2.4 | 1.5 | · | 6.5 | 1.7 | 0.4 | 0.5 | 1.1 | 1.0 | · | 3.0 | 0.8 |
Hisse Başına
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.67 | $0.33 | · | $1.06 | $0.74 | $1.25 | · | $1.91 | $0.92 | $1.70 | $3.13 | $2.77 | $1.77 | · | $2.00 | $2.32 | |
| Revenue / Share | $0.52 | $0.33 | · | $1.15 | $0.35 | $0.21 | · | $1.76 | $0.17 | $0.15 | $0.17 | $0.21 | $0.40 | · | $0.68 | $0.42 | |
| Cash Flow / Share | · | $-0.56 | · | · | · | $-0.74 | · | · | · | $-0.73 | · | · | $-0.21 | · | · | · | |
| Cash / Share | $1.79 | $1.05 | · | $1.27 | $2.07 | $2.31 | · | $2.86 | $1.34 | $1.28 | $1.45 | $1.76 | $3.63 | · | $1.37 | $0.35 | |
| EPS (TTM) | $-0.23 | $-1.11 | · | $-1.19 | $-0.56 | $-0.88 | · | $-1.57 | $-2.19 | $-0.38 | $0.79 | $0.11 | $-1.48 | · | $-3.10 | $-3.56 |
Değerleme (TTM)
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $168M | $142M | · | $112M | $150M | $154M | · | $141M | $41M | $43M | $121M | $152M | $165M | · | $93M | $67M | |
| Net Income TTM | $-15M | $-70M | · | $-76M | $-36M | $-56M | · | $-98M | $-136M | $-23M | $50M | $7M | $-91M | · | $-191M | $-219M | |
| Market Cap | $294M | $184M | · | $106M | $76M | $80M | · | $206M | $267M | $921M | $289M | $331M | $443M | · | $213M | $181M | |
| P/E | -20.1 | -2.6 | · | -1.4 | -2.2 | -1.4 | · | -2.1 | -1.9 | -38.7 | 5.9 | 48.6 | -4.8 | · | -1.1 | -0.8 | |
| P/S | 1.8 | 1.3 | · | 0.9 | 0.5 | 0.5 | · | 1.5 | 6.5 | 21.2 | 2.4 | 2.2 | 2.7 | · | 2.3 | 2.7 | |
| P/B | 6.9 | 8.7 | · | 1.6 | 1.6 | 1.0 | · | 1.7 | 4.6 | 8.7 | 1.5 | 1.9 | 4.1 | · | 1.7 | 1.3 | |
| P / Tangible Book | 6.9 | 8.7 | · | 1.6 | 1.6 | 1.0 | · | 1.7 | 4.6 | 8.7 | 1.5 | 1.9 | 4.1 | · | 1.7 | 1.3 | |
| P / Cash Flow | · | -5.1 | · | · | · | -1.7 | · | · | · | -20.2 | · | · | -34.6 | · | · | · | |
| Earnings Yield | -5.0% | -38.4% | · | -70.8% | -46.3% | -69.3% | · | -47.7% | -51.5% | -2.6% | 17.0% | 2.1% | -20.6% | · | -89.6% | -120.7% |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Gelir | $150M | $150M | $59M | $152M | $77M |
| Faaliyet Kâr Marjı % | -48.7% | -73.7% | -286.4% | -79.9% | -261.9% |
| Net Gelir | $-75M | $-67M | $-9M | $-120M | $-202M |
| Seyreltilmiş Hisse Başı Kâr | $-1.18 | $-1.07 | $-0.15 | $-1.95 | $-3.37 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Cari Oran | 5.1 | 3.9 | 4.5 | 4.6 | 3.7 |
| Cari Oran | 1.6 | 3.4 | 2.0 | 3.4 | 1.8 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $-83M | $-72M | $-80M | $-91M | $-150M |
Kurumsal Sahipler (13F) 135 dosya · $217.6M toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Sahipler
135
Tutulan Değer
$217.6M
Yeni pozisyonlar
40
Çıkan pozisyonlar
24
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 40 (+4 önceki Ç'ye göre) | 24 (+15 önceki Ç'ye göre) | 34 (+5 önceki Ç'ye göre) | 31 (+3 önceki Ç'ye göre) | +3.6M |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | $23.131.194 | 5.006.752 | 10,63% | Hisse senetleri |
| BlackRock, Inc. | $21.618.040 | 4.679.229 | 9,94% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $12.270.766 | 2.656.010 | 5,64% | Hisse senetleri |
| RENAISSANCE TECHNOLOGIES LLC | $12.163.305 | 2.632.750 | 5,59% | Hisse senetleri |
| BANK OF AMERICA CORP /DE/ | $11.495.724 | 2.488.252 | 5,28% | Hisse senetleri |
| TWO SIGMA INVESTMENTS, LP | $11.391.529 | 2.465.699 | 5,24% | Hisse senetleri |
| MILLENNIUM MANAGEMENT LLC | $10.969.248 | 2.374.296 | 5,04% | Hisse senetleri |
| RA CAPITAL MANAGEMENT, L.P. | $8.612.493 | 1.864.176 | 3,96% | Hisse senetleri |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $8.409.467 | 1.820.231 | 3,87% | Hisse senetleri |
| MACKENZIE FINANCIAL CORP | $7.588.932 | 1.642.626 | 3,49% | Hisse senetleri |
| MARSHALL WACE, LLP | $7.466.936 | 1.616.220 | 3,43% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $7.285.810 | 1.576.549 | 3,35% | Hisse senetleri |
| VANGUARD GROUP INC | $6.805.375 | 4.226.941 | 3,13% | Hisse senetleri |
| Affinity Asset Advisors, LLC | $5.620.720 | 1.216.606 | 2,58% | Hisse senetleri |
| D. E. Shaw & Co., Inc. | $4.911.018 | 1.062.991 | 2,26% | Hisse senetleri |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $4.630.506 | 1.002.274 | 2,13% | Hisse senetleri |
| Connor, Clark & Lunn Investment Management Ltd. | $4.621.903 | 1.000.412 | 2,12% | Hisse senetleri |
| WASATCH ADVISORS LP | $4.507.536 | 1.559.701 | 2,07% | Hisse senetleri |
| STATE STREET CORP | $3.990.123 | 863.663 | 1,83% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $2.577.964 | 558.001 | 1,18% | Hisse senetleri |
| NORTHERN TRUST CORP | $2.384.516 | 516.129 | 1,10% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $1.940.890 | 420.106 | 0,89% | Hisse senetleri |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $1.940.000 | 420.000 | 0,89% | Hisse senetleri |
| TWO SIGMA ADVISERS, LP | $1.923.950 | 1.195.000 | 0,88% | Hisse senetleri |
| Walleye Capital LLC | $1.885.653 | 408.150 | 0,87% | Hisse senetleri |
| DIMENSIONAL FUND ADVISORS LP | $1.753.576 | 379.335 | 0,81% | Hisse senetleri |
| DIADEMA PARTNERS LP | $1.729.742 | 374.403 | 0,80% | Hisse senetleri |
| PINNACLE ASSOCIATES LTD | $1.174.871 | 254.301 | 0,54% | Hisse senetleri |
| PANAGORA ASSET MANAGEMENT INC | $1.155.711 | 250.154 | 0,53% | Hisse senetleri |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $889.974 | 192.635 | 0,41% | Hisse senetleri |
| Man Group plc | $869.433 | 188.189 | 0,40% | Hisse senetleri |
| Amundi | $837.352 | 181.245 | 0,38% | Hisse senetleri |
| CITADEL ADVISORS LLC | $830.828 | 179.833 | 0,38% | Hisse senetleri |
| Informed Momentum Co LLC | $793.277 | 171.705 | 0,36% | Hisse senetleri |
| LPL Financial LLC | $786.615 | 170.263 | 0,36% | Hisse senetleri |
| SEI INVESTMENTS CO | $760.932 | 164.704 | 0,35% | Hisse senetleri |
| ROYAL BANK OF CANADA | $679.000 | 147.058 | 0,31% | Hisse senetleri |
| STRS OHIO | $658.350 | 142.500 | 0,30% | Hisse senetleri |
| Bank of New York Mellon Corp | $626.272 | 135.557 | 0,29% | Hisse senetleri |
| Nuveen, LLC | $608.698 | 131.753 | 0,28% | Hisse senetleri |
| ADAR1 Capital Management, LLC | $599.778 | 129.822 | 0,28% | Hisse senetleri |
| Squarepoint Ops LLC | $542.286 | 117.378 | 0,25% | Hisse senetleri |
| Invesco Ltd. | $475.790 | 102.985 | 0,22% | Hisse senetleri |
| Headlands Technologies LLC | $458.249 | 99.188 | 0,21% | Hisse senetleri |
| Susquehanna Portfolio Strategies, LLC | $446.689 | 96.686 | 0,21% | Hisse senetleri |
| Persistent Asset Partners Ltd | $440.614 | 95.371 | 0,20% | Hisse senetleri |
| MORGAN STANLEY | $428.681 | 92.788 | 0,20% | Hisse senetleri |
| JANE STREET GROUP, LLC | $387.442 | 83.862 | 0,18% | Hisse senetleri |
| FMR LLC | $386.315 | 83.618 | 0,18% | Hisse senetleri |
| XTX Topco Ltd | $351.393 | 76.059 | 0,16% | Hisse senetleri |
Şirket yöneticileri 27 içeriden öğrenenler · 11 yöneticiler · 15 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Eric Blasius Risser | President and CEO | 12 Şubat 2026 A | 77.169 | 0 | 0 | $0 |
| James Karrels | SVP and CFO | 12 Şubat 2026 A | 206.037 | 0 | 0 | $0 |
| Jeffrey Stuart Peters | Senior VP, GC, and Secretary | 19 Ağustos 2026 S | 0 | 0 | 1 | $-129.086 |
| Ezio Bonvini | Sr VP, Research & CSO | 17 Ağustos 2026 M | 185.799 | 0 | 0 | $0 |
| Beth Ann Smith | VP, Controller & Treasurer | 12 Şubat 2026 A | 12.781 | 0 | 0 | $0 |
| Thomas Spitznagel | Sr VP, Technical Ops | 12 Şubat 2026 A | 38.543 | 0 | 0 | $0 |
| Stephen L. Eck | Chief Medical Officer | 15 Şubat 2025 M | 29.377 | 0 | 0 | $0 |
| Lynn Cilinski | VP, Controller and Treasurer | 15 Şubat 2024 M | 6.213 | 0 | 0 | $0 |
| Jon Marc Wigginton | Sr VP, Clinical Dev. & CMO | 20 Şubat 2020 A | 18.930 | 0 | 0 | $0 |
| Kathryn E Stein | SVP, Product Dev. & Regulatory | 07 Ocak 2016 M | 95.555 | 0 | 0 | $0 |
| Stanford John Stewart | V P, Clinical Oncology | 09 Ekim 2013 A | · | 0 | 0 | $0 |
| Karen Jean Ferrante | Yönetim kurulu üyesi | 19 Mayıs 2026 A | 14.750 | 0 | 0 | $0 |
| Scott Koenig | Yönetim kurulu üyesi | 19 Mayıs 2026 A | 867.240 | 0 | 0 | $0 |
| Scott Thomas Jackson | Yönetim kurulu üyesi | 19 Mayıs 2026 A | 14.750 | 0 | 0 | $0 |
| William K Heiden | Yönetim kurulu üyesi | 19 Mayıs 2026 A | 114.750 | 0 | 0 | $0 |
| Edward Hurwitz | Yönetim kurulu üyesi | 19 Mayıs 2026 A | 47.824 | 0 | 0 | $0 |
| David C Stump | Yönetim kurulu üyesi | 19 Mayıs 2026 A | 14.750 | 0 | 0 | $0 |
| Federica F. O'Brien | Yönetim kurulu üyesi | 19 Mayıs 2026 A | 14.750 | 0 | 0 | $0 |
| Jay Philip Siegel | Yönetim kurulu üyesi | 18 Mayıs 2026 M | 14.750 | 0 | 0 | $0 |
| Meenu Chhabra | Yönetim kurulu üyesi | 18 Mayıs 2026 M | 14.750 | 0 | 0 | $0 |
| Kenneth Galbraith | Yönetim kurulu üyesi | 13 Mayıs 2021 A | 0 | 0 | 0 | $0 |
| Paulo F Costa | Yönetim kurulu üyesi | 13 Mayıs 2021 A | 59.435 | 0 | 0 | $0 |
| Matthew K Fust | Yönetim kurulu üyesi | 16 Mayıs 2019 A | 500 | 0 | 0 | $0 |
| Arnold L Oronsky | Yönetim kurulu üyesi | 18 Şubat 2014 S | 1.708.716 | 0 | 0 | $0 |
| Eran Nadav | Yönetim kurulu üyesi | 09 Ekim 2013 A | · | 0 | 0 | $0 |
| Margaret Liu | · | 19 Mayıs 2026 A | 14.750 | 0 | 0 | $0 |
| Atul Saran | · | 28 Nisan 2017 F | 16.986 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
ETF sahipliği 16 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,47% | 30.054 SH | 02 Ekim 2026 | Günlük |
| IWC · iShares Trust | 0,06% | 213.537 SH | 11 Eylül 2026 | Günlük |
| IWO · iShares Trust | 0,01% | 513.042 SH | 11 Eylül 2026 | Günlük |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 361.044 SH | 19 Ağustos 2026 | Günlük |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,01% | 58.897 SH | 19 Ağustos 2026 | Günlük |
| IWM · iShares Trust | 0,01% | 1.532.314 SH | 11 Eylül 2026 | Günlük |
| RSSL · Global X Funds | 0,01% | 29.881 NS | 31 Temmuz 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,00% | 20.270 SH | 02 Ekim 2026 | Günlük |
| DFAS · Dimensional ETF Trust | 0,00% | 65.703 NS | 31 Temmuz 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 3.958 NS | 31 Temmuz 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 666.535 SH | 19 Ağustos 2026 | Günlük |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1.925.510 SH | 19 Ağustos 2026 | Günlük |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,00% | 7.105 SH | 19 Ağustos 2026 | Günlük |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 5.334 SH | 19 Ağustos 2026 | Günlük |
| DFAC · Dimensional ETF Trust | 0,00% | 1.871 NS | 31 Temmuz 2026 | N-PORT |
| IWN · iShares Trust | · | 55.530 SH | 11 Eylül 2026 | Günlük |
MGNX Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
derecelendirme · 14 analist
AL
Medyan hedef
$8.50
+137,4%
3 21,4%
Güçlü Al
6 42,9%
Al
5 35,7%
Tut
0 0,0%
Sat
0 0,0%
Güçlü Sat
12 Aylık Fiyat Hedefi
4 analist · 2026-09-30Ortalama hedef $8.00 +123,5%
← Tüm hedeflerin altında
Mevcut fiyat $3.58
Düşük$4.00
Ortalama$8.00
Yüksek$11.00
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| MGNX | $102M | -1.4 | -0.31% | -49.9% | -87.0% | · |
| AKBA | $427M | -80.5 | 47.5% | -2.3% | -17.3% | · |
| IVVD | $697M | -8.2 | 110.5% | -98.2% | -36.9% | · |
| LYEL | $654M | -1.9 | -41.0% | -762355.6% | -100.3% | · |
| KROS | $398M | 8.9 | · | 35.7% | 17.2% | · |
| RNAC | $188M | -1.4 | -92.8% | -4658.6% | 202.4% | · |
| SION | $1.84B | -21.9 | · | · | -23.4% | · |
| TRDA | $394M | -3.0 | -87.9% | -565.5% | -41.9% | · |
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kaynak: SEC 10-Q dosyalandı Ağu 14, 2026